1102 related articles for article (PubMed ID: 16803598)
1. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
Vermitsky JP; Earhart KD; Smith WL; Homayouni R; Edlind TD; Rogers PD
Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
[TBL] [Abstract][Full Text] [Related]
2. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor.
Vermitsky JP; Edlind TD
Antimicrob Agents Chemother; 2004 Oct; 48(10):3773-81. PubMed ID: 15388433
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting fungal multidrug resistance by disrupting an activator-Mediator interaction.
Nishikawa JL; Boeszoermenyi A; Vale-Silva LA; Torelli R; Posteraro B; Sohn YJ; Ji F; Gelev V; Sanglard D; Sanguinetti M; Sadreyev RI; Mukherjee G; Bhyravabhotla J; Buhrlage SJ; Gray NS; Wagner G; Näär AM; Arthanari H
Nature; 2016 Feb; 530(7591):485-9. PubMed ID: 26886795
[TBL] [Abstract][Full Text] [Related]
4. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
Looi CY; D' Silva EC; Seow HF; Rosli R; Ng KP; Chong PP
FEMS Microbiol Lett; 2005 Aug; 249(2):283-9. PubMed ID: 16006060
[TBL] [Abstract][Full Text] [Related]
5. Relative Contribution of the ABC Transporters Cdr1, Pdh1, and Snq2 to Azole Resistance in Candida glabrata.
Whaley SG; Zhang Q; Caudle KE; Rogers PD
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30038038
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia.
Berila N; Borecka S; Dzugasova V; Bojnansky J; Subik J
Int J Antimicrob Agents; 2009 Jun; 33(6):574-8. PubMed ID: 19196495
[TBL] [Abstract][Full Text] [Related]
7. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
8. CgPDR1 gain-of-function mutations lead to azole-resistance and increased adhesion in clinical Candida glabrata strains.
Ni Q; Wang C; Tian Y; Dong D; Jiang C; Mao E; Peng Y
Mycoses; 2018 Jul; 61(7):430-440. PubMed ID: 29464833
[TBL] [Abstract][Full Text] [Related]
9. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of experimentally induced azole resistance in Candida glabrata.
Rogers PD; Vermitsky JP; Edlind TD; Hilliard GM
J Antimicrob Chemother; 2006 Aug; 58(2):434-8. PubMed ID: 16735426
[TBL] [Abstract][Full Text] [Related]
11. STB5 is a negative regulator of azole resistance in Candida glabrata.
Noble JA; Tsai HF; Suffis SD; Su Q; Myers TG; Bennett JE
Antimicrob Agents Chemother; 2013 Feb; 57(2):959-67. PubMed ID: 23229483
[TBL] [Abstract][Full Text] [Related]
12. Flucytosine antagonism of azole activity versus Candida glabrata: role of transcription factor Pdr1 and multidrug transporter Cdr1.
Steier Z; Vermitsky JP; Toner G; Gygax SE; Edlind T; Katiyar S
Antimicrob Agents Chemother; 2013 Nov; 57(11):5543-7. PubMed ID: 23979762
[TBL] [Abstract][Full Text] [Related]
13. Identification of genomic binding sites for Candida glabrata Pdr1 transcription factor in wild-type and ρ0 cells.
Paul S; Bair TB; Moye-Rowley WS
Antimicrob Agents Chemother; 2014 Nov; 58(11):6904-12. PubMed ID: 25199772
[TBL] [Abstract][Full Text] [Related]
14. RTA2, a novel gene involved in azole resistance in Candida albicans.
Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY
Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908
[TBL] [Abstract][Full Text] [Related]
15. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
[TBL] [Abstract][Full Text] [Related]
17. Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.
Nagayoshi Y; Miyazaki T; Shimamura S; Nakayama H; Minematsu A; Yamauchi S; Takazono T; Nakamura S; Yanagihara K; Kohno S; Mukae H; Izumikawa K
PLoS One; 2017; 12(7):e0180990. PubMed ID: 28700656
[TBL] [Abstract][Full Text] [Related]
18. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.
Coste AT; Ramsdale M; Ischer F; Sanglard D
Microbiology (Reading); 2008 May; 154(Pt 5):1491-1501. PubMed ID: 18451058
[TBL] [Abstract][Full Text] [Related]
19. Evidence that Ergosterol Biosynthesis Modulates Activity of the Pdr1 Transcription Factor in Candida glabrata.
Vu BG; Thomas GH; Moye-Rowley WS
mBio; 2019 Jun; 10(3):. PubMed ID: 31186322
[TBL] [Abstract][Full Text] [Related]
20. Local silencing controls the oxidative stress response and the multidrug resistance in Candida glabrata.
Orta-Zavalza E; Guerrero-Serrano G; Gutiérrez-Escobedo G; Cañas-Villamar I; Juárez-Cepeda J; Castaño I; De Las Peñas A
Mol Microbiol; 2013 Jun; 88(6):1135-48. PubMed ID: 23651300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
